Published in Arch Gen Psychiatry on April 01, 1998
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
Myelin and axon abnormalities in schizophrenia measured with magnetic resonance imaging techniques. Biol Psychiatry (2013) 1.64
Brain macrostructural and microstructural abnormalities in cocaine dependence. Drug Alcohol Depend (2007) 1.59
1H-MRS at 4 tesla in minimally treated early schizophrenia. Mol Psychiatry (2009) 1.40
Deconstructing psychosis with human brain imaging. Schizophr Bull (2007) 1.35
Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study. Schizophr Bull (2009) 1.25
Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res (2012) 1.23
Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr Res (2007) 1.19
In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatry (2000) 1.11
Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. Biol Psychiatry (2010) 1.10
A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage (2007) 1.09
Dysregulation of glutamate carboxypeptidase II in psychiatric disease. Schizophr Res (2008) 0.97
Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia. Schizophr Res (2011) 0.91
Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia. Schizophr Res (2009) 0.89
Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia. Int J Neurosci (2008) 0.85
Probing myelin and axon abnormalities separately in psychiatric disorders using MRI techniques. Front Integr Neurosci (2013) 0.83
Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J Psychiatry Neurosci (2005) 0.82
Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy. Magn Reson Med (2009) 0.80
Functional genomics and psychiatric illness. Prog Brain Res (2002) 0.78
T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia. Psychiatry Res (2013) 0.78
Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models. Alcohol Res (2017) 0.75
A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol (1994) 5.47
Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med (2000) 3.58
Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry (1999) 2.46
Magnitude least squares optimization for parallel radio frequency excitation design demonstrated at 7 Tesla with eight channels. Magn Reson Med (2008) 2.34
Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol Clin Exp Res (1992) 2.25
Correction for head size in brain-imaging measurements. Psychiatry Res (1993) 2.22
Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry (1992) 2.20
Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res (1995) 2.16
Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain (1991) 2.15
Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol Clin Exp Res (1997) 2.13
Equivalent disruption of regional white matter microstructure in ageing healthy men and women. Neuroreport (2001) 2.09
Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res (2000) 2.08
Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (2001) 2.02
A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry (1998) 1.93
Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics. Alcohol Clin Exp Res (1995) 1.83
ERPs to response production and inhibition. Electroencephalogr Clin Neurophysiol (1985) 1.78
In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholism. Alcohol Clin Exp Res (2000) 1.77
Cerebellar volume decline in normal aging, alcoholism, and Korsakoff's syndrome: relation to ataxia. Neuropsychology (2000) 1.70
Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology (2002) 1.69
In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med (1999) 1.66
Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging (1996) 1.61
Heritability of hippocampal size in elderly twin men: equivalent influence from genes and environment. Hippocampus (2001) 1.55
Reorganization of frontal systems used by alcoholics for spatial working memory: an fMRI study. Neuroimage (2001) 1.54
Sniffing and smelling: separate subsystems in the human olfactory cortex. Nature (1998) 1.47
Corpus callosal microstructural integrity influences interhemispheric processing: a diffusion tensor imaging study. Cereb Cortex (2005) 1.47
Dynamic shimming for multi-slice magnetic resonance imaging. Magn Reson Med (1997) 1.43
Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: relationships to changes in brain structure. Neuropsychology (2000) 1.42
Genetic regulation of regional microstructure of the corpus callosum in late life. Neuroreport (2001) 1.41
Differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson's disease. Arch Clin Neuropsychol (1998) 1.38
Combined event-related fMRI and EEG evidence for temporal-parietal cortex activation during target detection. Neuroreport (1997) 1.37
QUantitative Imaging of eXtraction of oxygen and TIssue consumption (QUIXOTIC) using venular-targeted velocity-selective spin labeling. Magn Reson Med (2011) 1.35
In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. J Magn Reson (1998) 1.35
Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol Psychiatry (2000) 1.34
Blind smell: brain activation induced by an undetected air-borne chemical. Brain (1999) 1.32
Neuroradiological characterization of normal adult ageing. Br J Radiol (2007) 1.30
Segmentation of MR brain images into cerebrospinal fluid spaces, white and gray matter. J Comput Assist Tomogr (1989) 1.29
Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiol Aging (2000) 1.29
Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood (1997) 1.28
Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biol Psychiatry (1994) 1.28
Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood (1996) 1.28
Thinning of the corpus callosum in older alcoholic men: a magnetic resonance imaging study. Alcohol Clin Exp Res (1996) 1.27
Odorant-induced and sniff-induced activation in the cerebellum of the human. J Neurosci (1998) 1.26
Echo-planar spin-echo and inversion pulses. Magn Reson Med (1993) 1.25
Differential rates of regional brain change in callosal and ventricular size: a 4-year longitudinal MRI study of elderly men. Cereb Cortex (2002) 1.23
Clinical application of the P3 component of event-related potentials. II. Dementia, depression and schizophrenia. Electroencephalogr Clin Neurophysiol (1984) 1.22
Mapping of the prostate in endorectal coil-based MRI/MRSI and CT: a deformable registration and validation study. Med Phys (2004) 1.21
Schizophrenics have fewer and smaller P300s: a single-trial analysis. Biol Psychiatry (1994) 1.21
Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry (2000) 1.20
Neuroimaging and the cognitive neuroscience of schizophrenia. Schizophr Bull (1996) 1.20
Time course of odorant-induced activation in the human primary olfactory cortex. J Neurophysiol (2000) 1.19
Motion correction and lipid suppression for 1H magnetic resonance spectroscopy. Magn Reson Med (2000) 1.19
Broadband slab selection with B1+ mitigation at 7T via parallel spectral-spatial excitation. Magn Reson Med (2009) 1.19
Clinical application of the P3 component of event-related potentials. I. Normal aging. Electroencephalogr Clin Neurophysiol (1984) 1.19
Functional neuroanatomy of auditory working memory in schizophrenia: relation to positive and negative symptoms. Neuroimage (2001) 1.18
Age-related loss of trabecular bone in premenopausal women: a biopsy study. Calcif Tissue Int (1983) 1.17
Physostigmine: improvement of long-term memory processes in normal humans. Science (1978) 1.16
Inhomogeneity correction for in vivo spectroscopy by high-resolution water referencing. Magn Reson Med (1992) 1.15
In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am J Neuroradiol (2000) 1.15
Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet (2000) 1.15
Penetrating head injury in young adulthood exacerbates cognitive decline in later years. J Neurosci (1989) 1.14
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain (1992) 1.13
Factors of the Wisconsin Card Sorting Test as measures of frontal-lobe function in schizophrenia and in chronic alcoholism. Psychiatry Res (1993) 1.12
Cortical and hippocampal volume deficits in temporal lobe epilepsy. Epilepsia (1997) 1.12
Structural MRI correlates of recognition memory in Alzheimer's disease. J Int Neuropsychol Soc (1998) 1.12
Functional magnetic resonance imaging evidence for disrupted basal ganglia function in schizophrenia. Am J Psychiatry (2001) 1.11
In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch Gen Psychiatry (1999) 1.10
Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease. Arch Neurol (1997) 1.08
Remote memory function in Alzheimer's disease and Parkinson's disease. Brain (1988) 1.08
ERPs in schizophrenia: effects of antipsychotic medication. Biol Psychiatry (1994) 1.08
P300 reduction and prolongation with illness duration in schizophrenia. Biol Psychiatry (2000) 1.08
Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. Arch Neurol (1995) 1.06